Scientists Identify Compounds That Stimulate Stem Cell Growth In The Brain
Scientists at Harvard University have identified key compounds that stimulate stem cell growth in the brain, which may one day lead to restored function for people affected by Parkinson’s disease, strokes, multiple sclerosis, and a wide range of neurological disorders.
Who Gives Stem Cells Their Marching Orders?
Researchers from the Swiss Institute for Experimental Cancer Research (ISREC) have shown that a single gene involved in embryonic development is responsible for two seemingly contradictory activities – maintaining stem cells after the embryo has implanted in the mother’s uterus, and later providing cues to direct their differentiation in a coordinated fashion when the time is ripe.
Genes Unique to the Human Egg Identified
The identification opens the way to understanding these genes’ functions, which may lead to solving problems from infertility to degenerative diseases.
Switching Off Aging in Stem Cells
A single molecular switch plays a central role in inducing stem cells in the brain, pancreas, and blood to lose function as they age, researchers have found.
Bio-Matrix Scientific Group Inc. to Unveil Stem Cell Extraction Devices
Bio-Matrix Scientific Group Inc. announced that it will unveil its new stem cell extraction kits at the American Association of Tissue Banks.
Lost in the Labyrinth
Recent research decodes the instructions that tell cells how to become blood.
Italians In Stem Cell Advances
Two teams of Italian scientists have made important advances in stem cell research that could pave the way for new treatments for kidney and liver disease.
Stem Cell and Myoblast Cotransplantation Improves Ventricular Function in Chagas Disease
Cellular transplantation is emerging as a promising strategy for the treatment of postinfarction ventricular dysfunction.
Introgen Therapeutics and Gendux AB Announce Orphan Designation for ADVEXIN Therapy in European Union
Gendux was notified by the European Medicines Agency (EMEA) Committee for Orphan Medicinal Products that ADVEXIN(R) p53 therapy has received Orphan Medicinal Product Designation in Europe for the treatment of Li-Fraumeni Syndrome (LFS).
Immunotherapy Shows Promise in Mild Heart Failure
Immune modulation therapy could benefit patients with mild heart failure, according to results of a large randomized, controlled trial.
Regulatory Clearance for Start of Patient Recruitment in 120-patient Phase II Trial of TroVax in Patients With Late-Stage Breast Cancer
Oxford BioMedica announces that the Southwest Oncology Group has received regulatory clearance to commence a Phase II trial of Oxford BioMedica’s cancer immunotherapy, TroVax, in patients with late-stage breast cancer.
Success of Gene Drug Trials Boosts Ark
Ark Therapeutics, maker of Cerepro has announced that it has successfully manufactured a batch of the medicine to commercial standards and its facilities have met European regulatory standards.
Vet First Out of Gate in Canada to Use Stem Cells in Treating Horses
An Alberta veterinarian is pushing the boundaries of medicine, becoming the first doctor in Canada to use emerging stem-cell technology to treat five injured horses.
Stem Cells Improve Child Brain Cancer Outcomes
A highly targeted treatment that relies on the patient’s own stem cells improves outcomes for children with brain tumors called medulloblastomas.
Mother and Toddler Caught in Stem Cell Scam
A Sydney mother determined to find treatment for her brain-damaged son has become the unwitting victim of an apparent international stem cell scam.
Stem Cell Firm Suspends Treatments
Advanced Cell Therapeutics has decided to temporarily suspend commercial treatments.
Stem Cells Could be Next Generation of Sports Doping
For athletes, stem cells have much more than the potential to cure disease and save lives — they may be able to heal injuries, boost strength and endurance, and provide a lasting edge over the competition.
ABSTRACTS, REVIEWS & SPECIAL REPORTS
Adipose-Derived Stem and Progenitor Cells as Fillers in Plastic and Reconstructive Surgery
Regenerative cell-based strategies such as those encompassing the use of stem cells hold tremendous promise for augmentation of the soft-tissue space. Preclinical studies and early clinical series show that adipose-derived stem cells offer the possibility of finally fulfilling the key principle of replacing like with like as an aesthetic filler, without the drawbacks of current technology.